These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8907385)

  • 21. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats.
    Frazier J; Yu L; Rhee E; Shaw L; LaRossa D; Rostami A
    J Hand Surg Am; 1993 Jan; 18(1):100-6. PubMed ID: 8423292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combined immune therapy on survival and Th1/Th2 cytokine balance in rat orthotopic liver transplantation.
    Cao H; Liu H; Wu ZY
    Chin Med J (Engl); 2007 Oct; 120(20):1809-12. PubMed ID: 18028776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
    Farivar AS; McCourtie AS; MacKinnon-Patterson BC; Woolley SM; Barnes AD; Chen M; Jagtap P; Szabó C; Salerno CT; Mulligan MS
    Ann Thorac Surg; 2005 Sep; 80(3):950-6. PubMed ID: 16122462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of blood transfusions on rat corneal graft survival.
    Ayliffe W; McLeod D; Hutchinson IV
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1974-8. PubMed ID: 1582802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
    Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
    Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term immunosuppression after rat parathyroid allotransplantation.
    Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
    Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of corneal allograft survival with leflunomide.
    Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with an HLA-peptide and cyclosporine A prolongs rat small bowel allograft survival.
    Willetts IE; Tam PK; Morris PJ; Dallman MJ
    J Pediatr Surg; 1997 Mar; 32(3):469-72. PubMed ID: 9094020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogenic skin graft].
    Zhao XF
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):495-7, 510. PubMed ID: 2620608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.
    Paul LC; Davidoff A; Benediktsson H
    Transplantation; 1994 Jun; 57(12):1767-72. PubMed ID: 7517077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased efficacy of CSA following rearterialization in the rat OLTX model.
    Freise CE; Liu T; Osorio RW; Ferrell L; Ascher NL; Roberts JP
    J Surg Res; 1995 Oct; 59(4):493-6. PubMed ID: 7564323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.